NOK 14.0
(-6.35%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 45.18 Million NOK | 160.9% |
2022 | 17.31 Million NOK | 8.7% |
2021 | 15.93 Million NOK | 548.22% |
2020 | 2.45 Million NOK | -65.43% |
2019 | 7.1 Million NOK | -34.28% |
2018 | 10.81 Million NOK | 462.97% |
2017 | 1.92 Million NOK | -26.94% |
2016 | 2.62 Million NOK | -21.32% |
2015 | 3.34 Million NOK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 23.92 Million NOK | 91.84% |
2024 Q1 | 12.47 Million NOK | -36.68% |
2023 Q3 | 8.62 Million NOK | 14.51% |
2023 Q1 | 8.31 Million NOK | -38.93% |
2023 Q4 | 19.69 Million NOK | 128.42% |
2023 FY | 45.18 Million NOK | 160.9% |
2023 Q2 | 7.52 Million NOK | -9.39% |
2022 Q4 | 13.6 Million NOK | 114.2% |
2022 Q2 | 1.62 Million NOK | 0.0% |
2022 FY | 17.31 Million NOK | 8.7% |
2022 Q3 | 6.35 Million NOK | 290.65% |
2021 FY | 15.93 Million NOK | 548.22% |
2020 FY | 2.45 Million NOK | -65.43% |
2019 FY | 7.1 Million NOK | -34.28% |
2018 FY | 10.81 Million NOK | 462.97% |
2017 FY | 1.92 Million NOK | -26.94% |
2016 FY | 2.62 Million NOK | -21.32% |
2015 FY | 3.34 Million NOK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Gentian Diagnostics ASA | 88.35 Million NOK | 48.866% |
Medistim ASA | 277.38 Million NOK | 83.712% |